Results 111 to 120 of about 120,603,510 (223)

Alpha-1-Antitrypsin-Mangel

open access: yes, 2009
ZusammenfassungDer Alpha-1-Antitrypsin-Mangel ist eine auto-somal-kodominant vererbbare Krankheit mit einer Prävalenz von 1:2000–1:5000. Typische klinische Merkmale sind die frühzeitige Entwicklung einer chronisch obstruktiven Lungenerkrankung mit ...
M. Dahlheim, N. Schwerk, M. Bredt
core   +1 more source

Vascular Pathology in Alpha 1 Antitrypsin Deficient Chronic Obstructive Pulmonary Disease and Emphysema Patients: Case Reports [PDF]

open access: yes
Matthew Gordon,1,* Andrew J Gangemi,1,* Eric L Sandwith,2,* Maruti Kumaran,3,* Friedrich Kueppers1,* 1Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA; 2HCA Florida
Gordon M   +4 more
core  

Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency-associated lung disease

open access: yesCochrane Database of Systematic Reviews
Alpha-1 antitrypsin (AAT) is a protein produced by the liver that stops certain enzymes from harming body tissues, especially in the lungs. AAT deficiency (AATD) is a genetic condition that can manifest clinically as chronic obstructive pulmonary disease (COPD), causing cough and breathlessness.
Glaister, Patrick   +5 more
openaire   +2 more sources

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes

open access: yes, 2015
Sanjay H Chotirmall,1 Mazen Al-Alawi,2 Thomas McEnery,2 Noel G McElvaney2 1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; 2Department of Respiratory Medicine, Beaumont Hospital, Dublin, Republic of Ireland Abstract ...
Chotirmall SH   +3 more
core  

Alpha 1 Antitrypsin Deficiency (AATD) Financial Cost

open access: yes
Explore the financial burdens of Alpha-1 Antitrypsin Deficiency, offering insights into treatment costs, economic impact, and innovative healthcare ...
Azhar ul Haque Sario
core   +1 more source

Patients with Alpha-1 Antitrypsin Deficiency: Disease Management Considerations

open access: yes
Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder that leads to decreased circulating levels of AAT, which significantly increases the risk of serious lung and liver disease.
Brian L. Tiep, Rick Carter
core   +1 more source

Alpha-1 antitrypsin and serum albumin levels in tear fluid of healthy subjects and in persons with conjunctival diseases

open access: yesIndian Journal of Ophthalmology, 1988
Alpha-1 antitrypsin and serum albumin levels were measured in the tear fluids in 81 healthy subjects and 142 patients with conjunctival diseases. The levels of the two proteins were independent of age and sex.
Sen D, Sarin G, Mathur M
doaj  

Liver:: Alpha-1-Antitrypsin Deficiency.

open access: yes, 1900
Alpha-1-antitrypsin deficiency. COMMENT: Bile stasis and a micronodular cirrhosis are seen in this example of enzyme deficiency disease.
MUSC Department of Pathology and Laboratory Medicine
core  

Alpha-1 Antitrypsin Deficiency

open access: yes, 2011
Overall goals and objectives: 1. To understand testing strategies for rare genetic diseases. 2. To understand the pathogenesis of lung and liver disease in Alpha-1 Antitrypsin deficiency. 3.
Strange, Charlie
core  

Home - About - Disclaimer - Privacy